Athene Holding Ltd.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Liquidity and Capital Resources
There are two forms of liquidity relevant to our business: funding liquidity and balance sheet liquidity. Funding liquidity relates to the ability to fund operations. Balance sheet liquidity relates to our ability to sell assets held in our investment portfolio without incurring significant costs from fees, bid-offer spreads, or market impact. We manage our liquidity position by matching projected cash demands with adequate sources of cash and other liquid assets. Our principal sources of liquidity, in the ordinary course of business, are operating cash flows and holdings of cash, cash equivalents and other readily marketable assets.
Our investment portfolio is structured to ensure a strong liquidity position over time to permit timely payment of policy and contract benefits without requiring asset sales at inopportune times or at depressed prices. In general, liquid assets include cash and cash equivalents, highly rated bonds, short-term investments, unaffiliated preferred stock and publicly traded common stock, all of which generally have liquid markets with a large number of buyers, but exclude pledged assets, mainly associated with funding agreement and repurchase agreement liabilities. The carrying value of these assets, excluding assets within modified coinsurance and funds withheld portfolios, as of September 30, 2026 was $119.3 billion. Assets included in modified coinsurance and funds withheld portfolios, including assets held in reinsurance trusts, are available to fund the benefits for the associated obligations but are restricted from other uses. The carrying value of the underlying assets in these modified coinsurance and funds withheld portfolios that we consider liquid as of September 30, 2026 was $8.2 billion. Although our investment portfolio does contain assets that are generally considered less liquid for liquidity monitoring purposes (primarily mortgage loans, policy loans, real estate and investment funds), there is some ability to raise cash from these assets if needed. In periods of economic downturn, we may seek to raise or hold additional cash and liquid assets to manage our liquidity risk and to take advantage of market dislocations as they arise.
We have access to additional liquidity through our Credit Facility and Liquidity Facility. We entered into a new Credit Facility on June 26, 2026, which replaced our previous agreement dated as of June 30, 2023. The Credit Facility has a borrowing capacity of $1.75 billion, subject to being increased up to $2.5 billion in total on the terms described in the Credit Facility. The Credit Facility has a commitment termination date of June 26, 2031, subject to up to two one-year extensions, and was undrawn as of September 30, 2026. We entered into a new Liquidity Facility on June 26, 2026, which replaced our previous agreement dated as of June 27, 2025. The Liquidity Facility has a borrowing capacity of $2.6 billion, subject to being increased up to $3.1 billion in total on the terms described in the Liquidity Facility. The Liquidity Facility has a commitment termination date of June 25, 2027, subject to additional 364-day extensions, and was undrawn as of September 30, 2026. We also have access to $2.0 billion of committed repurchase facilities. Our registration statement on Form S-3 ASR (Shelf Registration Statement) provides us with access to the capital markets, subject to market conditions and other factors. We are also the counterparty to repurchase agreements with several different financial institutions, pursuant to which we may obtain short-term liquidity, to the extent available. In addition, through our membership in the FHLB, we are eligible to borrow under variable-rate short-term federal funds arrangements to provide additional liquidity.
We proactively manage our liquidity position to meet cash needs while minimizing adverse impacts on investment returns. We analyze our cash-flow liquidity over the upcoming 12 months by modeling potential demands on liquidity under a variety of scenarios, taking into account the provisions of our policies and contracts in force, our cash flow position, and the volume of cash and readily marketable securities in our portfolio.
Liquidity risk is monitored, managed and mitigated through a number of stress tests and analyses to assess our ability to meet our cash flow requirements, as well as the ability of our reinsurance and insurance subsidiaries to meet their collateral obligations, under various stress scenarios. We further seek to mitigate liquidity risk by maintaining access to alternative, external sources of liquidity as described below.
Our liquidity risk management framework is codified in our Liquidity Risk Policy that is reviewed and approved by our board of directors.
Insurance Subsidiaries’ Liquidity
Operations
The primary cash flow sources for our insurance subsidiaries include retirement services product inflows (premiums and deposits), investment income, principal repayments on our investments, net transfers from separate accounts and financial product inflows. Uses of cash include investment purchases, payments to policyholders for surrenders, withdrawals and payout benefits, interest and principal payments on funding agreements and outstanding debt, payments to satisfy pension group annuity obligations, policy acquisition and general operating costs and payment of cash dividends.
Our policyholder obligations are generally long-term in nature. However, policyholders may elect to withdraw some or all of their account value in amounts that exceed our estimates and assumptions over the life of an annuity contract. We include provisions within our annuity policies, such as surrender charges and MVAs, which are intended to protect us from early withdrawals. As of September 30, 2026 and December 31, 2025, approximately 87% and 85%, respectively, of our deferred annuity liabilities were subject to penalty upon surrender. In addition, as of each of September 30, 2026 and December 31, 2025, approximately 69% of policies contained MVAs that may also have the effect of limiting early withdrawals if interest rates increase but may encourage early withdrawals by effectively subsidizing a portion of surrender charges when interest rates decrease. As of September 30, 2026, approximately 36% of our net reserve liabilities were generally non-surrenderable, including buy-out pension group annuities other than those that can be withdrawn as lump sums, funding agreements, payout annuities and guaranteed investment contracts, while 55% were subject to penalty upon surrender.
Membership in Federal Home Loan Bank
Through our membership in the FHLB, we are eligible to borrow under variable-rate short-term federal funds arrangements to provide additional liquidity. The borrowings must be secured by eligible collateral such as mortgage loans, eligible CMBS or RMBS, government or agency securities and guaranteed loans. As of each of September 30, 2026 and December 31, 2025, we had no outstanding borrowings under these arrangements.
We have issued funding agreements to the FHLB. These funding agreements were issued in an investment spread strategy, consistent with other investment spread operations. As of September 30, 2026 and December 31, 2025, we had funding agreements outstanding with the FHLB in the aggregate principal amount of $29.9 billion and $23.3 billion, respectively.
The maximum FHLB indebtedness by a member is determined by the amount of collateral pledged and cannot exceed a specified percentage of the member’s total statutory assets, dependent on the internal credit rating assigned to the member by the FHLB. As of September 30, 2026, our total maximum borrowing capacity under the FHLB facilities was limited to $74.7 billion. However, our ability to borrow under the facilities is constrained by the availability of assets that qualify as eligible collateral under the facilities and certain other limitations. Considering these limitations, as of September 30, 2026, we had the ability to draw up to an estimated $33.8 billion, inclusive of borrowings then outstanding. This estimate is based on our internal analysis and assumptions and may not accurately measure collateral that is ultimately acceptable to the FHLB.
Securities Repurchase Agreements
We engage in repurchase transactions whereby we sell fixed income securities to third parties, primarily major brokerage firms or commercial banks, with a concurrent agreement to repurchase such securities at a determined future date. We require that, at all times during the term of the repurchase agreements, we maintain sufficient cash or other liquid assets to allow us to fund substantially all of the repurchase price. Proceeds received from the sale of securities pursuant to these arrangements are generally invested in short-term investments or maintained in cash, with the offsetting obligation to repurchase the security included within payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets. Under the terms of the repurchase agreements, we monitor the market value of the securities sold and may be required to deliver additional collateral (which may be in the form of cash or additional securities) to the extent the value of the securities sold decreases prior to the repurchase date.
As of September 30, 2026 and December 31, 2025, the payables for repurchase agreements were $3.6 billion and $6.0 billion, respectively, while the fair value of securities and collateral held by counterparties backing the repurchase agreements was $3.7 billion and $6.2 billion, respectively. As of September 30, 2026, payables for repurchase agreements, based on original issuance, included $329 million short-term and $3.2 billion of long-term repurchase agreements. As of December 31, 2025, payables for repurchase agreements, based on original issuance, included $2.8 billion of short-term and $3.2 billion of long-term repurchase agreements.
We have a $1.0 billion committed repurchase facility with BNP Paribas. The facility has an initial commitment period of 12 months and automatically renews for successive 12-month periods until terminated by either party. During the commitment period, we may sell and BNP Paribas is required to purchase eligible investment grade corporate bonds pursuant to repurchase transactions at pre-agreed discounts in exchange for a commitment fee. As of September 30, 2026, we had no outstanding payables under this facility.
We entered into a new $1.0 billion committed repurchase facility with Societe Generale effective July 26, 2026, which replaced our previous agreement dated as of July 26, 2021. The facility has a commitment term of 5 years; however, either party may terminate the facility upon 12 months’ notice, in which case the facility will end upon the earlier of (1) such designated termination date, or (2) July 26, 2031. During the commitment period, we may sell and Societe Generale is required to purchase eligible investment grade corporate bonds pursuant to repurchase transactions at pre-agreed rates in exchange for an ongoing commitment fee for the facility. As of September 30, 2026, we had no outstanding payables under this facility.
Cash Flows
Our cash flows were as follows:
| Nine months ended September 30, | ||
|---|---|---|
| (In millions) | 2026 | 2025 |
| Net income (loss) | $(1,115) | $3,323 |
| Non-cash revenues and expenses | 4,573 | (1,205) |
| Net cash provided by operating activities | 3,458 | 2,118 |
| Sales, maturities and repayments of investments | 76,341 | 60,684 |
| Purchases of investments | (120,332) | (110,597) |
| Other investing activities | 4,862 | (391) |
| Net cash used in investing activities | (39,129) | (50,304) |
| Inflows on investment-type policies and contracts | 60,237 | 69,269 |
| Withdrawals on investment-type policies and contracts | (24,433) | (16,821) |
| Other financing activities | 1,565 | (568) |
| Net cash provided by financing activities | 37,369 | 51,880 |
| Effect of exchange rate changes on cash and cash equivalents | (2) | 13 |
| Net increase in cash and cash equivalents | $1,696 | $3,707 |
| Note: Cash and cash equivalents includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities. | ||
Cash flows from operating activities
The primary cash inflows from operating activities include net investment income and insurance premiums. The primary cash outflows from operating activities are composed of benefit and interest payments as well as other operating expenses. Our operating activities generated cash flows totaling $3.5 billion and $2.1 billion for the nine months ended September 30, 2026 and 2025, respectively. The increase in cash provided by operating activities for the nine months ended September 30, 2026 compared to 2025 was primarily driven by an increase in net investment income, less cash paid for taxes, an increase in premiums, net of payouts, and less cash paid on reinsurance settlements, partially offset by an increase in cash paid for interest on funding agreements and other operating expenses.
Cash flows from investing activities
The primary cash inflows from investing activities are the sales, maturities and repayments of investments. The primary cash outflows from investing activities are the purchases and acquisitions of new investments. Our investing activities used cash flows totaling $39.1 billion and $50.3 billion for the nine months ended September 30, 2026 and 2025, respectively. The decrease in cash used in investing activities for the nine months ended September 30, 2026 compared to 2025 was primarily driven by an increase in the sales, maturities and repayments of investments, an increase in investment payables, net of receivables, and a smaller increase in cash posted as collateral by us for derivative transactions compared to 2025, partially offset by an increase in the purchases of investments and an increase in cash paid for derivative settlements in 2026.
Cash flows from financing activities
The primary cash inflows from financing activities are inflows on our investment-type policies and contracts, changes in cash collateral for derivative transactions posted by counterparties, capital contributions and proceeds from debt and preferred stock issuances. The primary cash outflows from financing activities are withdrawals on our investment-type policies and contracts, changes in cash collateral for derivative transactions posted by counterparties, capital distributions, repayments of outstanding borrowings and payment of preferred and common stock dividends. Our financing activities provided cash flows totaling $37.4 billion and $51.9 billion for the nine months ended September 30, 2026 and 2025, respectively. The decrease in cash provided by financing activities for the nine months ended September 30, 2026 compared to 2025 was primarily attributable to less cash received from deferred annuity and funding agreement inflows, an increase in cash paid for withdrawals on our investment-type policies and contracts and less cash received from the issuance of long-term debt compared to 2025, partially offset by an increase in cash collateral posted by counterparties for derivative transactions, less cash paid to settle outstanding repurchase agreements, cash paid for the redemption of our Series C preferred stock in 2025 and an increase in capital contributions, net of distributions, compared to 2025.
Material Cash Obligations
The following table summarizes estimated future cash obligations as of September 30, 2026:
| Payments Due by Period | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | 2026 | 2027-2028 | 2029-2030 | 2031 and thereafter | Total | |||
| Interest sensitive contract liabilities | $7,091 | $99,102 | $101,004 | $146,902 | $354,099 | |||
| Future policy benefits | 797 | 5,485 | 4,897 | 33,987 | 45,166 | |||
| Market risk benefits | — | — | — | 6,877 | 6,877 | |||
| Other policy claims and benefits | 108 | — | — | — | 108 | |||
| Dividends payable to policyholders | 3 | 17 | 14 | 53 | 87 | |||
| Debt1 | 149 | 1,983 | 1,405 | 15,061 | 18,598 | |||
| Securities to repurchase2 | 369 | 2,378 | 1,146 | — | 3,893 | |||
| Total | $8,517 | $108,965 | $108,466 | $202,880 | $428,828 | |||
| 1 The obligations for debt payments include contractual maturities of principal and estimated future interest payments based on the terms of the debt agreements. | ||||||||
| 2 The obligations for securities to repurchase payments include contractual maturities of principal and estimated future interest payments based on the terms of the agreements. Future interest payments on floating rate repurchase agreements were calculated using the September 30, 2026 interest rate. | ||||||||
Holding Company Liquidity
Common Stock Dividends
We intend to pay regular common stock dividends to our parent company of $750 million per year, generally paid at the end of each quarter; provided that the declaration and payment of any dividends are at the sole discretion of our board of directors, which may change the dividend policy at any time, including, without limitation, eliminating the dividend entirely.
We declared common stock cash dividends of $188 million on August 3, 2026, payable to the holder of AHL’s common stock with a record date of September 11, 2026 and payment date of September 15, 2026. We have paid $563 million in common stock cash dividends for the nine months ended September 30, 2026.
We declared and paid common stock cash dividends of $188 million and $563 million for the three months ended September 30, 2025 and the nine months ended September 30, 2025, respectively.
Dividends from Insurance Subsidiaries
AHL is a holding company whose primary liquidity needs include the cash flow requirements relating to its corporate activities, including its day-to-day operations, debt servicing, preferred and common stock dividend payments and strategic transactions, such as acquisitions. The primary sources of AHL’s cash flows are dividends from its subsidiaries, capital market issuances and intercompany borrowings, which are expected to be adequate to fund cash flow requirements based on current estimates of future obligations.
The ability of AHL’s insurance subsidiaries to pay dividends is limited by applicable laws and regulations of the jurisdictions where the subsidiaries are domiciled, as well as agreements entered into with regulators. These laws and regulations require, among other things, the insurance subsidiaries to maintain minimum solvency requirements and limit the amount of dividends these subsidiaries can pay.
Subject to these limitations and prior notification to the appropriate regulatory agency, the US insurance subsidiaries are permitted to pay ordinary dividends based on calculations specified under insurance laws of the relevant state of domicile. Any distributions above the amount permitted by statute in any twelve-month period are considered to be extraordinary dividends, and require the approval of the appropriate regulator prior to payment. AHL does not currently plan on having the US subsidiaries pay any dividends to their parents.
Dividends from subsidiaries are projected to be the primary source of AHL’s liquidity. Under the Bermuda Insurance Act, each of our Bermuda insurance subsidiaries is prohibited from paying a dividend in an amount exceeding 25% of the prior year’s statutory capital and surplus, unless at least two members of the board of directors of the Bermuda insurance subsidiary and its principal representative in Bermuda sign and submit to the Bermuda Monetary Authority (BMA) an affidavit attesting that a dividend in excess of this amount would not cause the Bermuda insurance subsidiary to fail to meet its relevant margins. In certain instances, the Bermuda insurance subsidiary would also be required to provide prior notice to the BMA in advance of the payment of dividends. In the event that such an affidavit is submitted to the BMA in accordance with the Bermuda Insurance Act, and further subject to the Bermuda insurance subsidiary meeting its relevant margins, the Bermuda insurance subsidiary is permitted to distribute up to the sum of 100% of statutory surplus and an amount less than 15% of its total statutory capital. Distributions in excess of this amount require the approval of the BMA.
The maximum distribution permitted by law or contract is not necessarily indicative of our actual ability to pay such distributions, which may be further restricted by business and other considerations, such as the impact of such distributions on surplus, which could affect our ratings or competitive position and the amount of premiums that can be written. Specifically, the level of capital needed to maintain desired financial strength ratings from rating agencies, including S&P, A.M. Best, Fitch and Moody’s, is of particular concern when determining the amount of capital available for distributions. AHL believes its insurance subsidiaries have sufficient statutory capital and surplus, combined with additional capital available to be provided by AHL, to meet their financial strength ratings objectives. Finally, state insurance laws and regulations require that the statutory surplus of our insurance subsidiaries following any dividend or distribution must be reasonable in relation to their outstanding liabilities and adequate for the insurance subsidiaries’ financial needs.
Other Sources of Funding
We may seek to secure additional funding at the holding company level by means other than dividends from subsidiaries, such as by drawing on our undrawn $1.75 billion Credit Facility or by pursuing future issuances of debt or preferred stock to third-party investors. Certain other sources of liquidity potentially available at the holding company level are discussed below. Our Credit Facility contains various standard covenants with which we must comply, including maintaining a consolidated debt-to-capitalization ratio of not greater than 40%, maintaining a minimum consolidated net worth of no less than $22.1 billion and restrictions on our ability to incur liens, with certain exceptions. Rates, ratios and terms are as defined in the Credit Facility.
Shelf Registration –Under our Shelf Registration Statement, subject to market conditions, we have the ability to issue, in indeterminate amounts, debt securities, preferred stock, depositary shares, warrants and units.
Debt –The following summarizes our outstanding long-term senior and subordinated notes as of September 30, 2026 (in millions, except percentages):
| Issuance | Issue Date | Maturity Date | Interest Rate | Principal Balance |
|---|---|---|---|---|
| 2028 Senior Notes | January 12, 2018 | January 12, 2028 | 4.125% | $1,000 |
| 2030 Senior Notes | April 3, 2020 | April 3, 2030 | 6.150% | $500 |
| 2031 Senior Notes | October 8, 2020 | January 15, 2031 | 3.500% | $500 |
| 2051 Senior Notes | May 25, 2021 | May 25, 2051 | 3.950% | $500 |
| 2052 Senior Notes | December 13, 2021 | May 15, 2052 | 3.450% | $500 |
| 2033 Senior Notes | November 21, 2022 | February 1, 2033 | 6.650% | $400 |
| 2034 Senior Notes | December 12, 2023 | January 15, 2034 | 5.875% | $600 |
| 2064 Subordinated Notes | March 7, 2024 | March 30, 2064 | 7.250%1 | $575 |
| 2054 Senior Notes | March 22, 2024 | April 1, 2054 | 6.250% | $1,000 |
| 2054 Subordinated Notes | October 10, 2024 | October 15, 2054 | 6.625%2 | $600 |
| 2055 Senior Notes | May 19, 2025 | May 19, 2055 | 6.625% | $1,000 |
| 2055 Subordinated Notes | June 27, 2025 | June 28, 2055 | 6.875%3 | $600 |
| 2036 Senior Notes | August 7, 2026 | August 15, 2036 | 6.150% | $1,000 |
| 1 The 2064 Subordinated Notes bear interest at an annual fixed rate of 7.250% until March 30, 2029. On March 30, 2029, and every fifth anniversary thereafter, the interest rate resets to the five-year US Treasury rate (as defined in the applicable prospectus supplement) plus 2.986%. | ||||
| 2 The 2054 Subordinated Notes bear interest at an annual fixed rate of 6.625% until October 15, 2034. On October 15, 2034, and every fifth anniversary thereafter, the interest rate resets to the five-year US Treasury rate (as defined in the applicable prospectus supplement) plus 2.607%. | ||||
| 3 The 2055 Subordinated Notes bear interest at an annual fixed rate of 6.875% until June 28, 2035. On June 28, 2035, and every fifth anniversary thereafter, the interest rate resets to the five-year US Treasury rate (as defined in the applicable prospectus supplement) plus 2.582%. | ||||
See Note 8 – Debt to the condensed consolidated financial statements and Note 11 – Debtto the consolidated financial statements in our 2025 Annual Report for further information on debt.
Preferred Stock –The following summarizes our perpetual non-cumulative preferred stock issuances as of September 30, 2026 (in millions, except share, per share data and percentages):
| Issuance | Fixed/Floating | Rate | Issue Date | Optional Redemption Date1 | Shares Issued | Par Value Per Share | Liquidation Value Per Share | Aggregate Net Proceeds |
|---|---|---|---|---|---|---|---|---|
| Series A | Fixed-to-Floating Rate | 6.350% | June 10, 2019 | June 30, 2029 | 34,500 | $1.00 | $25,000 | $839 |
| Series B | Fixed-Rate | 5.625% | September 19, 2019 | September 30, 2024 | 13,800 | $1.00 | $25,000 | $333 |
| Series D | Fixed-Rate | 4.875% | December 18, 2020 | December 30, 2025 | 23,000 | $1.00 | $25,000 | $557 |
| Series E | Fixed-Rate Reset | 7.750% | December 12, 2022 | Variable2 | 20,000 | $1.00 | $25,000 | $487 |
| 1 We may redeem preferred stock any time on or after the dates set forth in this column, subject to the terms of the applicable certificate of designations. | ||||||||
| 2 We may redeem during a period from and including December 30 of each year in which there is a Reset Date to and including such Reset Date. Reset Date means December 30, 2027 and each date falling on the fifth anniversary of the preceding Reset Date. | ||||||||
See Note 12 – Equity to the consolidated financial statements in our 2025 Annual Report for further information on preferred stock.
Unsecured Revolving Promissory Note Payable with AGM – AHL has an unsecured revolving promissory note with AGM that allows AHL to borrow funds from AGM. The note has a borrowing capacity of $500 million and a maturity date of December 13, 2028, or earlier at AGM’s request. There was no outstanding balance on the note payable as of September 30, 2026.
Intercompany Note –AHL has an unsecured revolving note payable with ALRe, which permits AHL to borrow up to $4.0 billion with a fixed interest rate of 2.29% and a maturity date of December 15, 2028. As of September 30, 2026 and December 31, 2025, the revolving note payable had an outstanding balance of $3.1 billion and $2.2 billion, respectively.
Capital
We believe we have a strong capital position and are well positioned to meet policyholder and other obligations. We measure capital sufficiency using various internal capital metrics that reflect management’s view on the various risks inherent to our business, the amount of capital required to support our core operating strategies and the amount of capital necessary to maintain our current ratings in a recessionary environment. The amount of capital required to support our core operating strategies is determined based upon internal modeling and analysis of economic risk, as well as inputs from rating agency capital models and consideration of both NAIC risk-based capital (RBC) and Bermuda capital requirements. Capital in excess of this required amount is considered excess equity capital, which is available to deploy.
As of December 31, 2025 and 2024, our US insurance companies’ total adjusted capital (TAC), as defined by the NAIC, was $9.5 billion and $7.7 billion, respectively, and our US RBC ratio was 436% and 419%, respectively. Each US domestic insurance subsidiary’s state of domicile imposes minimum RBC requirements that were developed by the NAIC. The formulas for determining the amount of RBC specify various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of TAC to its authorized control level RBC. Our TAC was significantly in excess of all regulatory standards as of December 31, 2025 and 2024, respectively.
Bermuda statutory capital and surplus for our Bermuda insurance companies in aggregate was $18.6 billion and $17.0 billion as of December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, our Bermuda RBC ratio was 454% and 450%, respectively. The Bermuda RBC ratio is calculated using Bermuda Capital (as defined below) and applying NAIC RBC factors on an aggregate basis, excluding US subsidiaries which are included within our US RBC ratio. Bermuda Capital represents the capital of Athene’s non-US reinsurance subsidiaries as reported in the Bermuda statutory financial statements, adjusted to exclude deferred tax assets related to Bermuda CIT. Bermuda statutory financial statements apply US statutory accounting principles for policyholder reserve liabilities, which we subject to US cash flow testing requirements. There are certain differences between Bermuda statutory and US statutory frameworks that result in Consolidated RBC being approximately 20 RBC points higher as of December 31, 2025. The primary driver of this difference is that Bermuda statutory financial statements require that assets assumed as part of a reinsurance transaction and any assets sold are recorded at their market value, without posting an interest maintenance reserve. We expect this difference to reduce over time, and to decline to immaterial levels over the next five years. Our Bermuda insurance companies adhere to BMA regulatory capital requirements to maintain statutory capital and surplus to meet the minimum margin of solvency and maintain minimum Economic Balance Sheet (EBS) capital and surplus to meet the enhanced capital requirement (ECR). Under the EBS framework, assets are recorded at market value and insurance reserves are determined by reference to nine prescribed scenarios, with the scenario resulting in the highest reserve balance being ultimately required to be selected. For the Bermuda group, which includes the capital and surplus of AARe and all of its subsidiaries, including AAIA and its subsidiaries, EBS capital and surplus resulted in a Bermuda Solvency Capital Requirement (BSCR) ratio, computed as available statutory economic capital and surplus divided by ECR, of 202% and 243% as of December 31, 2025 and 2024, respectively. An insurer must have a BSCR ratio of 100% or greater to be considered solvent by the BMA. As of December 31, 2025 and 2024, our Bermuda insurance companies held the appropriate capital to adhere to these regulatory standards.
As of December 31, 2025 and 2024, our consolidated statutory capital and surplus in the aggregate was $28.5 billion and $24.8 billion, respectively, and our consolidated RBC ratio was 441% and 430%, respectively. Our consolidated regulatory capital represents the aggregate capital of our US and Bermuda insurance entities, determined with respect to each insurance entity by applying the statutory accounting principles applicable to each such entity with adjustments made to, among other things, assets and expenses at the holding company level. The Consolidated RBC ratio is calculated by aggregating US RBC and Bermuda RBC, with immaterial adjustments for net assets at the holding company.
ACRA 1 – ACRA 1 provided us with access to on-demand capital to support our growth strategies and capital deployment opportunities. ACRA 1 provided a capital source to fund both our inorganic and organic channels. ALRe directly owns 37% of the economic interests in ACRA 1 and all of ACRA 1’s voting interests, with ADIP I owning the remaining 63% of the economic interests. The commitment period for ACRA 1 expired in August 2023.
ACRA 2 – Similar to ACRA 1, we funded ACRA 2 in December 2022 as another long-duration, on-demand capital vehicle. ALRe directly owns 37% of the economic interests in ACRA 2 and all of ACRA 2’s voting interests, with ADIP II owning the remaining 63% of the economic interests. ACRA 2 participates in certain transactions by drawing a portion of the required capital for such transactions from third-party investors equal to ADIP II’s proportionate economic interests in ACRA 2.
These stockholder-friendly, strategic capital solutions allow us the flexibility to simultaneously deploy capital across multiple accretive avenues, while maintaining a strong financial position.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.